• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过小干扰RNA(siRNA)沉默DLGAP5可显著抑制肝癌细胞的增殖和侵袭。

Silencing of DLGAP5 by siRNA significantly inhibits the proliferation and invasion of hepatocellular carcinoma cells.

作者信息

Liao Weijia, Liu Weilong, Yuan Qing, Liu Xing, Ou Ying, He Songqing, Yuan Shengguang, Qin Liling, Chen Qian, Nong Kate, Mei Minghui, Huang Jian

机构信息

Institute of Hepatobiliary Surgery, Hospital Affiliated of Guilin Medical University, Guangxi Key Laboratory of Molecular Medicine, People's Republic of China in liver injury and repair, Hepatology Institute of Guilin Medical University, Guilin, Guangxi Zhuang Autonomous Region, China.

出版信息

PLoS One. 2013 Dec 4;8(12):e80789. doi: 10.1371/journal.pone.0080789. eCollection 2013.

DOI:10.1371/journal.pone.0080789
PMID:24324629
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3851768/
Abstract

BACKGROUND

The dysregulation of oncogenes and tumor suppressor genes plays an important role in many cancers, including hepatocellular carcinoma (HCC), which is one of the most common cancers in the world. In a previous microarray experiment, we found that DLGAP5 is overexpressed in HCCs. However, whether the up-regulation of DLGAP5 contributes to hepatocarcinogenesis remains unclear.

METHODOLOGY/PRINCIPAL FINDINGS: In this study, we showed that DLGAP5 was significantly up-regulated in 76.4% (168 of 220) of the analyzed HCC specimens when compared with adjacent liver tissue. DLGAP5 overexpression was evident in 25% (22 of 88) of the HCC specimens without AFP expression, suggesting that DLGAP5 may be a novel biomarker for HCC pathogenesis. The silencing of DLGAP5 gene expression by RNA interference significantly suppressed cell growth, migration and colony formation in vitro. The expression level of DLGAP5 was also found to be related to the methylation level of its promoter in the HCC specimens.

CONCLUSIONS/SIGNIFICANCE: Taken together, these data suggest that the expression of DLGAP5 is regulated by methylation and that the up-regulation of DLGAP5 contributes to HCC tumorigenesis by promoting cell proliferation.

摘要

背景

癌基因和肿瘤抑制基因的失调在包括肝细胞癌(HCC)在内的许多癌症中起重要作用,肝细胞癌是世界上最常见的癌症之一。在先前的一项微阵列实验中,我们发现DLGAP5在肝癌中过表达。然而,DLGAP5的上调是否有助于肝癌发生仍不清楚。

方法/主要发现:在本研究中,我们发现与相邻肝组织相比,在76.4%(220个中的168个)分析的肝癌标本中DLGAP5显著上调。在25%(88个中的22个)无甲胎蛋白表达的肝癌标本中DLGAP5过表达明显,提示DLGAP5可能是肝癌发病机制的一种新型生物标志物。通过RNA干扰沉默DLGAP5基因表达可显著抑制体外细胞生长、迁移和集落形成。还发现肝癌标本中DLGAP5的表达水平与其启动子的甲基化水平有关。

结论/意义:综上所述,这些数据表明DLGAP5的表达受甲基化调控,且DLGAP5的上调通过促进细胞增殖有助于肝癌的发生。

相似文献

1
Silencing of DLGAP5 by siRNA significantly inhibits the proliferation and invasion of hepatocellular carcinoma cells.通过小干扰RNA(siRNA)沉默DLGAP5可显著抑制肝癌细胞的增殖和侵袭。
PLoS One. 2013 Dec 4;8(12):e80789. doi: 10.1371/journal.pone.0080789. eCollection 2013.
2
Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinoma.作为一种假定的肿瘤抑制基因,分泌型卷曲相关蛋白1(SFRP1)的下调可能导致人类肝细胞癌。
BMC Cancer. 2007 Jul 12;7:126. doi: 10.1186/1471-2407-7-126.
3
Reduced expression of DACT2 promotes hepatocellular carcinoma progression: involvement of methylation-mediated gene silencing.DACT2 表达降低促进肝细胞癌进展:涉及甲基化介导的基因沉默。
World J Surg Oncol. 2013 Mar 7;11:57. doi: 10.1186/1477-7819-11-57.
4
Methylation-regulated miR-124-1 suppresses tumorigenesis in hepatocellular carcinoma by targeting CASC3.甲基化调控的miR-124-1通过靶向CASC3抑制肝细胞癌的肿瘤发生。
Oncotarget. 2016 May 3;7(18):26027-41. doi: 10.18632/oncotarget.8266.
5
Expression of a novel gene FAM43B repressing cell proliferation is regulated by DNA methylation in hepatocellular carcinoma cell lines.新型基因 FAM43B 的表达受肝癌细胞系中 DNA 甲基化的调控,该基因可抑制细胞增殖。
Mol Cell Biochem. 2011 Aug;354(1-2):11-20. doi: 10.1007/s11010-011-0800-y. Epub 2011 Apr 2.
6
GATA5 inhibits hepatocellular carcinoma cells malignant behaviours by blocking expression of reprogramming genes.GATA5 通过阻断重编程基因的表达抑制肝癌细胞的恶性行为。
J Cell Mol Med. 2019 Apr;23(4):2536-2548. doi: 10.1111/jcmm.14144. Epub 2019 Jan 22.
7
Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.WWP1的过表达促进肿瘤发生,并预示肝细胞癌患者的预后不良。
Oncotarget. 2015 Dec 1;6(38):40920-33. doi: 10.18632/oncotarget.5712.
8
The suppressive role and aberrent promoter methylation of BTG3 in the progression of hepatocellular carcinoma.BTG3 在肝细胞癌进展中的抑制作用和异常启动子甲基化。
PLoS One. 2013 Oct 17;8(10):e77473. doi: 10.1371/journal.pone.0077473. eCollection 2013.
9
ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma.ESM-1 沉默降低了肝癌细胞的存活率、迁移和侵袭能力,并调节了细胞周期进程。
Amino Acids. 2011 Mar;40(3):1003-13. doi: 10.1007/s00726-010-0729-6. Epub 2010 Sep 7.
10
IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.IGF2 通过表观遗传机制在肝细胞癌中上调,并且是实验模型中可操作的癌基因产物。
Gastroenterology. 2016 Dec;151(6):1192-1205. doi: 10.1053/j.gastro.2016.09.001. Epub 2016 Sep 7.

引用本文的文献

1
Exercise-related immune gene signature for hepatocellular carcinoma: machine learning and multi-omics analysis.肝细胞癌的运动相关免疫基因特征:机器学习与多组学分析
Front Immunol. 2025 Jun 20;16:1606711. doi: 10.3389/fimmu.2025.1606711. eCollection 2025.
2
Network-based analysis of candidate oncogenes and pathways in hepatocellular carcinoma.基于网络的肝细胞癌候选致癌基因和信号通路分析
Biochem Biophys Rep. 2025 Jun 10;43:102086. doi: 10.1016/j.bbrep.2025.102086. eCollection 2025 Sep.
3
Identification of exosome-related genes associated with prognosis and immune infiltration features in pancreatic cancer.

本文引用的文献

1
Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up.肝细胞癌:ESMO-ESDO诊断、治疗及随访临床实践指南
Ann Oncol. 2012 Oct;23 Suppl 7:vii41-8. doi: 10.1093/annonc/mds225.
2
Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development.肝转化生长因子 β 产生肿瘤起始细胞并促进肝癌发展。
Hepatology. 2012 Dec;56(6):2255-67. doi: 10.1002/hep.26007.
3
Efficient typing of copy number variations in a segmental duplication-mediated rearrangement hotspot using multiplex competitive amplification.
胰腺癌中与预后及免疫浸润特征相关的外泌体相关基因的鉴定
Discov Oncol. 2025 Feb 17;16(1):192. doi: 10.1007/s12672-025-01961-1.
4
Statistical and machine learning based platform-independent key genes identification for hepatocellular carcinoma.基于统计和机器学习的肝细胞癌平台无关关键基因识别
PLoS One. 2025 Feb 5;20(2):e0318215. doi: 10.1371/journal.pone.0318215. eCollection 2025.
5
GD-Net: An Integrated Multimodal Information Model Based on Deep Learning for Cancer Outcome Prediction and Informative Feature Selection.GD-Net:一种基于深度学习的集成多模态信息模型,用于癌症预后预测和信息性特征选择。
J Cell Mol Med. 2024 Dec;28(23):e70221. doi: 10.1111/jcmm.70221.
6
Unveiling novel prognostic biomarkers and therapeutic targets for HBV-associated hepatocellular carcinoma through integrated bioinformatic analysis.通过综合生物信息学分析揭示乙型肝炎病毒相关性肝细胞癌的新型预后生物标志物和治疗靶点。
Medicine (Baltimore). 2024 Oct 25;103(43):e40134. doi: 10.1097/MD.0000000000040134.
7
Recent Advances in RNA Interference-Based Therapy for Hepatocellular Carcinoma: Emphasis on siRNA.基于 RNA 干扰的肝细胞癌治疗的最新进展:重点是 siRNA。
Cell Biochem Biophys. 2024 Sep;82(3):1947-1964. doi: 10.1007/s12013-024-01395-6. Epub 2024 Jul 10.
8
DLGAP5 triggers proliferation and metastasis of bladder cancer by stabilizing E2F1 via USP11.DLGAP5 通过 USP11 稳定 E2F1 促进膀胱癌的增殖和转移。
Oncogene. 2024 Feb;43(8):594-607. doi: 10.1038/s41388-023-02932-y. Epub 2024 Jan 5.
9
Momordicine I suppresses glioma growth by promoting apoptosis and impairing mitochondrial oxidative phosphorylation.苦瓜素I通过促进细胞凋亡和损害线粒体氧化磷酸化来抑制胶质瘤生长。
EXCLI J. 2023 Jun 6;22:482-498. doi: 10.17179/excli2023-6129. eCollection 2023.
10
Hypoxia-based classification and prognostic signature for clinical management of hepatocellular carcinoma.基于缺氧的肝细胞癌临床管理分类和预后标志物。
World J Surg Oncol. 2023 Jul 22;21(1):216. doi: 10.1186/s12957-023-03090-x.
使用多重竞争扩增技术对串联重复介导的重排热点中的拷贝数变异进行高效分型。
J Hum Genet. 2012 Aug;57(8):545-51. doi: 10.1038/jhg.2012.66. Epub 2012 Jun 7.
4
HDGF-related protein-3 is required for anchorage-independent survival and chemoresistance in hepatocellular carcinomas.HDGF 相关蛋白-3 对于肝癌的锚定非依赖性存活和化疗耐药性是必需的。
Gut. 2013 Mar;62(3):440-51. doi: 10.1136/gutjnl-2011-300781. Epub 2012 Apr 5.
5
Knockdown of HURP inhibits the proliferation of hepacellular carcinoma cells via downregulation of gankyrin and accumulation of p53.HURP 敲低通过下调 gankyrin 和 p53 积累抑制肝细胞癌细胞的增殖。
Biochem Pharmacol. 2012 Mar 15;83(6):758-68. doi: 10.1016/j.bcp.2011.12.034. Epub 2011 Dec 31.
6
Combined expression of BUB1B, DLGAP5, and PINK1 as predictors of poor outcome in adrenocortical tumors: validation in a Brazilian cohort of adult and pediatric patients.BUB1B、DLGAP5 和 PINK1 的联合表达可预测肾上腺皮质肿瘤的不良预后:巴西成人和儿科患者队列的验证。
Eur J Endocrinol. 2012 Jan;166(1):61-7. doi: 10.1530/EJE-11-0806. Epub 2011 Nov 2.
7
Expression of the Transmembrane Glycoprotein CD44s Is Potentially an Independent Predictor of Recurrence in Hepatocellular Carcinoma.跨膜糖蛋白 CD44s 的表达可能是肝细胞癌复发的独立预测因子。
Gut Liver. 2011 Jun;5(2):204-9. doi: 10.5009/gnl.2011.5.2.204. Epub 2011 Jun 23.
8
Up-regulation of Krüppel-like factor 8 promotes tumor invasion and indicates poor prognosis for hepatocellular carcinoma.Krüppel 样因子 8 的上调促进肝癌的侵袭,并预示着肝癌患者预后不良。
Gastroenterology. 2010 Dec;139(6):2146-2157.e12. doi: 10.1053/j.gastro.2010.08.004. Epub 2010 Aug 19.
9
CD151 modulates expression of matrix metalloproteinase 9 and promotes neoangiogenesis and progression of hepatocellular carcinoma.CD151 调节基质金属蛋白酶 9 的表达,促进肝癌的新生血管生成和进展。
Hepatology. 2010 Jul;52(1):183-96. doi: 10.1002/hep.23661.
10
High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma.高表达的肝干细胞/祖细胞标志物与肿瘤血管生成和肝细胞癌不良预后相关。
Gut. 2010 Jul;59(7):953-62. doi: 10.1136/gut.2008.176271. Epub 2010 May 4.